{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:02:24Z","timestamp":1785333744889,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154242","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:06:02Z","timestamp":1783177562000},"page":"154242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis"],"prefix":"10.1016","volume":"830","author":[{"given":"Ti","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianqiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154242_bib1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1136\/gutjnl-2025-334928","article-title":"Systemic treatment in patients with hepatocellular carcinoma and advanced liver dysfunction","volume":"74","author":"Pinter","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2026.154242_bib2","article-title":"Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma","volume":"1880","author":"Zhang","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.bbrc.2026.154242_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.22.00392","article-title":"Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)","volume":"41","author":"Peng","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2026.154242_bib4","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14712598.2025.2557625","article-title":"Combining VEGF and PD-1\/PD-L1 inhibition in advanced hepatocellular carcinoma: clinical trials, real-world evidence, and future directions","volume":"25","author":"Balsano","year":"2025","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2026.154242_bib5","article-title":"Immune microenvironment and immunotherapy in hepatocellular carcinoma: mechanisms and advances","volume":"16","author":"Xie","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154242_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175913","article-title":"Understanding sorafenib-induced ferroptosis and resistance mechanisms: implications for cancer therapy","volume":"955","author":"Li","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154242_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154242_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154242_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115933","article-title":"Ferroptosis resistance in cancer: recent advances and future perspectives","volume":"219","author":"Zhang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154242_bib10","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.bbrc.2026.154242_bib11","article-title":"SHP-1\/STAT3-Signaling-Axis-Regulated coupling between BECN1 and SLC7A11 contributes to sorafenib-induced ferroptosis in hepatocellular carcinoma","volume":"23","author":"Huang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2026.154242_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101052","article-title":"Dual specific phosphatase 4 suppresses ferroptosis and enhances sorafenib resistance in hepatocellular carcinoma","volume":"73","author":"Hao","year":"2024","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154242_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101181","article-title":"5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1\/SLC7A11-mediated ferroptosis","volume":"78","author":"Shi","year":"2025","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.bbrc.2026.154242_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jare.2025.07.003","article-title":"The GOLM1-ACLY pathway regulates macrophage-secreted EFEMP1 via H3K27ac modifications to drive tumor progression","volume":"82","author":"Zhen","year":"2026","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbrc.2026.154242_bib15","article-title":"Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154242_bib16","article-title":"Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma","volume":"8","author":"Yang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154242_bib17","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1245\/s10434-009-0790-0","article-title":"Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis","volume":"17","author":"Nomoto","year":"2010","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.bbrc.2026.154242_bib18","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.3892\/or.2016.4733","article-title":"EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1\/2 activity","volume":"35","author":"Dou","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbrc.2026.154242_bib19","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1002\/cam4.2144","article-title":"Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting semaphorin 3B(SEMA3B)","volume":"8","author":"Hu","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbrc.2026.154242_bib20","doi-asserted-by":"crossref","DOI":"10.1515\/med-2024-1084","article-title":"Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer","volume":"20","author":"Wang","year":"2025","journal-title":"Open Med."},{"key":"10.1016\/j.bbrc.2026.154242_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.15403\/jgld-6499","article-title":"Knockdown of EFEMP1 promotes ferroptosis by inactivating PI3K\/AKT to overcome the resistance of hepatocellular carcinoma cells to sorafenib","volume":"35","author":"Zhou","year":"2026","journal-title":"J. Gastrointest. Liver Dis."},{"key":"10.1016\/j.bbrc.2026.154242_bib22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41568-023-00633-y","article-title":"Deubiquitinases in cancer","volume":"23","author":"Dewson","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2026.154242_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1204","article-title":"The roles of E3 ubiquitin ligases in cancer progression and targeted therapy","volume":"13","author":"Sampson","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154242_bib24","article-title":"Core fucosylation represses SMURF1-Dependent degradation of CD47 to promote tumor immune evasion","author":"Cao","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.bbrc.2026.154242_bib25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1080\/15548627.2019.1570063","article-title":"Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth","volume":"15","author":"Feng","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2026.154242_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217470","article-title":"circCCNY enhances lenvatinib sensitivity and suppresses immune evasion in hepatocellular carcinoma by serving as a scaffold for SMURF1 mediated HSP60 degradation","volume":"612","author":"Yang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbrc.2026.154242_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-022-00788-0","article-title":"Novel FLT3\/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma","volume":"29","author":"Lai","year":"2022","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bbrc.2026.154242_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1177\/10668969221126122","article-title":"The diagnostic and prognostic significance of EFEMP1 in breast cancer: an immunohistochemistry study","volume":"31","author":"Fararjeh","year":"2023","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.bbrc.2026.154242_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.108564","article-title":"HIPK4 accelerates cutaneous squamous cell carcinoma progression by phosphorylating TAp63 and inhibiting EFEMP1 expression","volume":"301","author":"Guo","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154242_bib30","article-title":"Decrease of fibulin-3 in hepatocellular carcinoma indicates poor prognosis","volume":"8","author":"Luo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154242_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119879","article-title":"GALNT6, transcriptionally inhibited by KLF9, promotes osteosarcoma progression by increasing EFEMP1 expression via O-glycosylation modification","volume":"1872","author":"Tong","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.bbrc.2026.154242_bib32","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1111\/jcmm.12394","article-title":"Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential","volume":"18","author":"Almeida","year":"2014","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrc.2026.154242_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.675","article-title":"METTL1-m(7) G-EGFR\/EFEMP1 axis promotes the bladder cancer development","volume":"11","author":"Ying","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbrc.2026.154242_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66319-1","article-title":"USP29 and SMURF1 orchestrate FSP1-mediated ferroptosis suppression to facilitate chemoresistance in gastric cancer","volume":"16","author":"Wu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2026.154242_bib35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41419-023-05873-2","article-title":"SMURF1 attenuates endoplasmic reticulum stress by promoting the degradation of KEAP1 to activate NRF2 antioxidant pathway","volume":"14","author":"Dong","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2026.154242_bib36","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of ferroptosis sensitization and resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2026.154242_bib37","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1158\/0008-5472.CAN-22-4001","article-title":"DPP9 stabilizes NRF2 to suppress ferroptosis and induce sorafenib resistance in clear cell renal cell carcinoma","volume":"83","author":"Chang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154242_bib38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13046-024-03061-4","article-title":"PLAG1 interacts with GPX4 to conquer vulnerability to sorafenib induced ferroptosis through a PVT1\/miR-195-5p axis-dependent manner in hepatocellular carcinoma","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154242_bib39","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s10620-025-08890-7","article-title":"NFAT2 induces tumor cell proliferation and metastasis by acting as a transcriptional Co-activator of the TGF-\u03b21\/SMAD signaling pathway and inducing the epithelial-mesenchymal transition in liver cancer","volume":"70","author":"Liu","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbrc.2026.154242_bib40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjh.16156","article-title":"GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression","volume":"188","author":"Fang","year":"2020","journal-title":"Br. J. Haematol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:10:59Z","timestamp":1785330659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0006291X26010065"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154242","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMURF1-mediated EFEMP1 ubiquitination reverses the resistance of HCC cells to sorafenib by promoting ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154242"}}